Back to search results

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

Abroad (travel likely)RecruitingPHASE4

Conditions

HIV-1-infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Helios Salud, Buenos Aires, Argentina

  • Hospital del Niño, Panama City, Panama

  • University of Stellenbosch, Cape Town, South Africa

  • Enhancing Care Foundation, Durban, South Africa

  • WITS RHI Research Centre, Johannesburg, South Africa

  • Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa

  • Be Part Yoluntu Centre, Paarl, South Africa

  • The Aurun Institute, Pretoria, South Africa

  • Perinatal HIV Research Unit, Soweto, South Africa

  • Faculty of Medicine - Mahidol University, Bangkok Noi, Thailand

  • Khon Kaen University, Khon Kaen, Thailand

  • Joint Clinical Research Centre, Kampala, Uganda

  • MU-JHU Research Collaboration/MU-JHU Care Ltd, Kampala, Uganda

  • Baylor College of Medicine, Kampala, Uganda

  • University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe

Study leads

  • Gilead Study Director

    Study Director

    Gilead Sciences

View source on ClinicalTrials.gov(opens in a new tab)